New insights into systemic sclerosis / / edited by Michal Tomcik.

Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic fe...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:London, United Kingdom : : IntechOpen,, [2019]
©2019
Year of Publication:2019
Language:English
Physical Description:1 online resource (160 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01062nam a2200313 i 4500
001 993544010404498
005 20221019220821.0
006 m o d
007 cr |||||||||||
008 221019s2019 enka ob 000 0 eng d
020 |a 1-83962-206-7 
020 |a 1-83962-205-9 
035 |a (CKB)4920000000094428 
035 |a (NjHacI)994920000000094428 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/54593 
035 |a (EXLCZ)994920000000094428 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
041 0 |a eng 
050 4 |a RC924.5.S34  |b .N49 2019 
082 0 4 |a 616.544  |2 23 
100 1 |a Michal Tomcik  |4 auth 
245 0 0 |a New insights into systemic sclerosis /  |c edited by Michal Tomcik. 
260 |b IntechOpen  |c 2019 
264 1 |a London, United Kingdom :  |b IntechOpen,  |c [2019] 
264 4 |c ©2019 
300 |a 1 online resource (160 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022). 
504 |a Includes bibliographical references. 
520 |a Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma. 
546 |a English 
650 0 |a Systemic scleroderma. 
653 |a Medicine 
653 |a Immunopathology 
653 |a Immunology 
653 |a Allergology and Rheumatology 
653 |a Health Sciences 
776 |z 1-83962-204-0 
700 1 |a Tomcik, Michal ,  |e editor. 
906 |a BOOK 
ADM |b 2023-02-22 21:26:42 Europe/Vienna  |f system  |c marc21  |a 2019-11-10 04:18:40 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351662700004498&Force_direct=true  |Z 5351662700004498  |b Available  |8 5351662700004498